Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Leukemia, Myeloid, Chronic
Interventions: DRUG: Bosutinib
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer